Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain

Kentaro Deguchi, Kazunori Miyazaki, Fengfeng Tian, Ning Liu, Wentao Liu, Hiromi Kawai, Yosiho Omote, Syoichiro Kono, Taijun Yunoki, Shoko Deguchi, Koji Abe

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Changes in expression of neurorepair and neuroregenerative factors were examined after transient cerebral ischemia in relation to the effects of tissue plasminogen activator (tPA) and the free radical scavenger edaravone. Physiological saline or edaravone was injected twice during 90 min of transient middle cerebral artery occlusion (tMCAO) in rats, followed by the same saline or tPA at reperfusion. Sizes of the infarct and protein factors relating to neurorepair and neuroregeneration were examined at 4 d after tMCAO. The protein factors examined were: a chondroitin sulfate proteoglycan neurocan, semaphorin type 3A (Sema3A), a myelin-associated glycoprotein receptor (Nogo receptor, Nogo-R), a synaptic regenerative factor (growth associated protein-43, GAP43), and a chemotropic factor netrin receptor (deleted in colorectal cancer, DCC). Two groups treated by edaravone only or edaravone plus tPA showed a reduction in infarct volume compared to the two groups treated by vehicle only or vehicle plus tPA. Immunohistochemistry and western blot analyses indicated that protein expression of neurocan, Sema3A, Nogo-R, GAP43, and DCC was decreased with tPA, but recovered with edaravone. Additive edaravone prevented the reductions of these five proteins induced by tPA. The present study demonstrates for the first time that exogenous tPA reduced protein factors involved in inhibiting and promoting axonal growth, but that edaravone ameliorated such damage in brain repair after acute ischemia.

Original languageEnglish
Pages (from-to)168-177
Number of pages10
JournalBrain Research
Volume1436
DOIs
Publication statusPublished - Feb 3 2012

Fingerprint

Middle Cerebral Artery Infarction
Tissue Plasminogen Activator
Brain
Neurocan
Semaphorin-3A
GAP-43 Protein
Proteins
Colorectal Neoplasms
Myelin-Associated Glycoprotein
Chondroitin Sulfate Proteoglycans
Free Radical Scavengers
Transient Ischemic Attack
phenylmethylpyrazolone
Reperfusion
Ischemia
Western Blotting
Immunohistochemistry
Growth

Keywords

  • Acute ischemia
  • Axonal growth
  • Edaravone
  • Neuroregeneration
  • Neurorepair
  • Tissue plasminogen activator

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain. / Deguchi, Kentaro; Miyazaki, Kazunori; Tian, Fengfeng; Liu, Ning; Liu, Wentao; Kawai, Hiromi; Omote, Yosiho; Kono, Syoichiro; Yunoki, Taijun; Deguchi, Shoko; Abe, Koji.

In: Brain Research, Vol. 1436, 03.02.2012, p. 168-177.

Research output: Contribution to journalArticle

Deguchi, Kentaro ; Miyazaki, Kazunori ; Tian, Fengfeng ; Liu, Ning ; Liu, Wentao ; Kawai, Hiromi ; Omote, Yosiho ; Kono, Syoichiro ; Yunoki, Taijun ; Deguchi, Shoko ; Abe, Koji. / Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain. In: Brain Research. 2012 ; Vol. 1436. pp. 168-177.
@article{4342663d2f54459e9eb74e5c8af0eacf,
title = "Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain",
abstract = "Changes in expression of neurorepair and neuroregenerative factors were examined after transient cerebral ischemia in relation to the effects of tissue plasminogen activator (tPA) and the free radical scavenger edaravone. Physiological saline or edaravone was injected twice during 90 min of transient middle cerebral artery occlusion (tMCAO) in rats, followed by the same saline or tPA at reperfusion. Sizes of the infarct and protein factors relating to neurorepair and neuroregeneration were examined at 4 d after tMCAO. The protein factors examined were: a chondroitin sulfate proteoglycan neurocan, semaphorin type 3A (Sema3A), a myelin-associated glycoprotein receptor (Nogo receptor, Nogo-R), a synaptic regenerative factor (growth associated protein-43, GAP43), and a chemotropic factor netrin receptor (deleted in colorectal cancer, DCC). Two groups treated by edaravone only or edaravone plus tPA showed a reduction in infarct volume compared to the two groups treated by vehicle only or vehicle plus tPA. Immunohistochemistry and western blot analyses indicated that protein expression of neurocan, Sema3A, Nogo-R, GAP43, and DCC was decreased with tPA, but recovered with edaravone. Additive edaravone prevented the reductions of these five proteins induced by tPA. The present study demonstrates for the first time that exogenous tPA reduced protein factors involved in inhibiting and promoting axonal growth, but that edaravone ameliorated such damage in brain repair after acute ischemia.",
keywords = "Acute ischemia, Axonal growth, Edaravone, Neuroregeneration, Neurorepair, Tissue plasminogen activator",
author = "Kentaro Deguchi and Kazunori Miyazaki and Fengfeng Tian and Ning Liu and Wentao Liu and Hiromi Kawai and Yosiho Omote and Syoichiro Kono and Taijun Yunoki and Shoko Deguchi and Koji Abe",
year = "2012",
month = "2",
day = "3",
doi = "10.1016/j.brainres.2011.12.016",
language = "English",
volume = "1436",
pages = "168--177",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain

AU - Deguchi, Kentaro

AU - Miyazaki, Kazunori

AU - Tian, Fengfeng

AU - Liu, Ning

AU - Liu, Wentao

AU - Kawai, Hiromi

AU - Omote, Yosiho

AU - Kono, Syoichiro

AU - Yunoki, Taijun

AU - Deguchi, Shoko

AU - Abe, Koji

PY - 2012/2/3

Y1 - 2012/2/3

N2 - Changes in expression of neurorepair and neuroregenerative factors were examined after transient cerebral ischemia in relation to the effects of tissue plasminogen activator (tPA) and the free radical scavenger edaravone. Physiological saline or edaravone was injected twice during 90 min of transient middle cerebral artery occlusion (tMCAO) in rats, followed by the same saline or tPA at reperfusion. Sizes of the infarct and protein factors relating to neurorepair and neuroregeneration were examined at 4 d after tMCAO. The protein factors examined were: a chondroitin sulfate proteoglycan neurocan, semaphorin type 3A (Sema3A), a myelin-associated glycoprotein receptor (Nogo receptor, Nogo-R), a synaptic regenerative factor (growth associated protein-43, GAP43), and a chemotropic factor netrin receptor (deleted in colorectal cancer, DCC). Two groups treated by edaravone only or edaravone plus tPA showed a reduction in infarct volume compared to the two groups treated by vehicle only or vehicle plus tPA. Immunohistochemistry and western blot analyses indicated that protein expression of neurocan, Sema3A, Nogo-R, GAP43, and DCC was decreased with tPA, but recovered with edaravone. Additive edaravone prevented the reductions of these five proteins induced by tPA. The present study demonstrates for the first time that exogenous tPA reduced protein factors involved in inhibiting and promoting axonal growth, but that edaravone ameliorated such damage in brain repair after acute ischemia.

AB - Changes in expression of neurorepair and neuroregenerative factors were examined after transient cerebral ischemia in relation to the effects of tissue plasminogen activator (tPA) and the free radical scavenger edaravone. Physiological saline or edaravone was injected twice during 90 min of transient middle cerebral artery occlusion (tMCAO) in rats, followed by the same saline or tPA at reperfusion. Sizes of the infarct and protein factors relating to neurorepair and neuroregeneration were examined at 4 d after tMCAO. The protein factors examined were: a chondroitin sulfate proteoglycan neurocan, semaphorin type 3A (Sema3A), a myelin-associated glycoprotein receptor (Nogo receptor, Nogo-R), a synaptic regenerative factor (growth associated protein-43, GAP43), and a chemotropic factor netrin receptor (deleted in colorectal cancer, DCC). Two groups treated by edaravone only or edaravone plus tPA showed a reduction in infarct volume compared to the two groups treated by vehicle only or vehicle plus tPA. Immunohistochemistry and western blot analyses indicated that protein expression of neurocan, Sema3A, Nogo-R, GAP43, and DCC was decreased with tPA, but recovered with edaravone. Additive edaravone prevented the reductions of these five proteins induced by tPA. The present study demonstrates for the first time that exogenous tPA reduced protein factors involved in inhibiting and promoting axonal growth, but that edaravone ameliorated such damage in brain repair after acute ischemia.

KW - Acute ischemia

KW - Axonal growth

KW - Edaravone

KW - Neuroregeneration

KW - Neurorepair

KW - Tissue plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=84856004974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856004974&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2011.12.016

DO - 10.1016/j.brainres.2011.12.016

M3 - Article

C2 - 22221736

AN - SCOPUS:84856004974

VL - 1436

SP - 168

EP - 177

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -